Newsletter | August 5, 2022

08.05.22 -- Why Priothera Is Our Company To Watch

New Podcast Episode
Featured Articles
Companies To Watch: Priothera

Priothera is bent on boosting the safety and effectiveness of hematopoietic stem cell transplantation for blood cancers.

Aside From Publications, What Can Academic Scientists Do To Promote Their Research And Discoveries To Potential Licensees Or Drug Developers?

See the answer from Chandra Ramanathan, an executive in residence at MassGeneral Brigham and who serves on the board of directors of MassBIO.

Outsourcers Who Most Heavily Rely On CDMOs Often Lack CDMO Selection Resources

The 2022 iteration of ISR’s CDMO Outsourcing Models report relays similarities and differences in how outsourcing decisions are made at drug innovator companies of various sizes.

Web-Exclusive Content
Online Resource Launched To Ease Clinical Trial Participation Fears

Studies have shown that patients are eager to participate in clinical trials, but they lack the resources to address their fears. Fear remains the main barrier to patient participation. Earlier this year, an independent start-up launched an online resource for patients to access information they need to ease their fears.

Industry Insights
What Big CROs Don’t Want You To Know About Staffing Scalability For Phase 3 Studies

Don’t settle for recycled employees poached from other studies when therapeutically-aligned, passionate, and accountable personnel — eager to work on your specific study — are available.

Reversing The Complexity Of Oncology Commercialization

Pharma manufacturers must now understand how to navigate influence points within the healthcare ecosystem and support patients through the navigation of access, reimbursement, and affordability barriers.

Digital Edition
August 2022 Digital Edition

Inside you will find more on:

  • Regulatory Issues
  • Big Pharma Exec Interviews
  • Leadership Lessons
  • Clinical Trials

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.